HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (HSDT)

CUSIP: 42328V801

Q4 2023 13F Holders as of 31 Dec 2023

Share change
+1,714
SEC-reported price per share
$8.04
Number of holders
11
Value change
+$13,778
Number of buys
4
Number of sells
2

Security key

42328V801

Report period

Q4 2023

Institutions

11

Top holders

10

Ownership snapshot

Top reported holders of HSDT - HELIUS MEDICAL TECHNOLOGIES, INC. - COM CL A NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Mitch E. Tyler
Disclosed value leader
Mitch E. Tyler
Comparable rows
0/11
Latest evidence
30 Sep 2023
3/4/5 13F Highest disclosed value: $130,823 11 rows are not safely comparable across share classes. Showing 1-6 of 11 holder rows.

Quick read

Mitch E. Tyler has the largest disclosed position value at $130.8K.

0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Mitch E. Tyler's linked filing trail.
Disclosed position value Top 5
Mitch E. Tyler $130.8K
VANGUARD GROUP INC $107.8K
BlackRock Finance, Inc. $48.5K
Tower Research Capital LLC (TRC) $8.8K
OSAIC HOLDINGS, INC. $1.6K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 11 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Mitch E. Tyler
3/4/5
Director
—
mixed-class rows
$130,823
27,701 shares
mixed-class rows
— 25 May 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$107,835
11,363 shares
— 30 Sep 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$48,456
5,106 shares
— 30 Sep 2023
Tower Research Capital LLC (TRC)
13F
Company
13F
—
denominator unverified
$8,845
932 shares
— 30 Sep 2023
OSAIC HOLDINGS, INC.
13F
Company
13F
—
denominator unverified
$1,556
164 shares
— 30 Sep 2023
UBS Group AG
13F
Company
13F
—
denominator unverified
$769
81 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
11
Shares
19,445
Rows available
11
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q4 2025 Across Filers

Q4 2025 holders
1
Q4 2023 holders
11
Holder diff
10
Investor Q4 2025 Shares Q4 2023 Shares Share Diff Share Chg % Q4 2025 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .